104 related articles for article (PubMed ID: 3491369)
1. Action of chronically administered antidepressants on the serotonergic postsynapse in a model of depression.
Nagayama H; Akiyoshi J; Tobo M
Pharmacol Biochem Behav; 1986 Oct; 25(4):805-11. PubMed ID: 3491369
[TBL] [Abstract][Full Text] [Related]
2. Postsynaptic action by four antidepressive drugs in an animal model of depression.
Nagayama H; Hingtgen JN; Aprison MH
Pharmacol Biochem Behav; 1981 Jul; 15(1):125-30. PubMed ID: 6974869
[TBL] [Abstract][Full Text] [Related]
3. Postsynaptic serotonergic blockade following chronic antidepressive treatment with trazodone in an animal model of depression.
Hingtgen JN; Hendrie HC; Aprison MH
Pharmacol Biochem Behav; 1984 Mar; 20(3):425-8. PubMed ID: 6608737
[TBL] [Abstract][Full Text] [Related]
4. Response suppression in rats after bilateral microinjection of 5-hydroxytryptophan in lateral hypothalamus.
Hingtgen JN; Shekhar A; DiMicco JA; Aprison MH
Biol Psychiatry; 1988 Apr; 23(7):711-8. PubMed ID: 3259438
[TBL] [Abstract][Full Text] [Related]
5. Effect of antidepressants, lithium and electroconvulsive treatment on rat serum prolactin levels.
Meltzer HY; Simonovic M; Sturgeon RD; Fang VS
Acta Psychiatr Scand Suppl; 1981; 290():100-21. PubMed ID: 6971560
[TBL] [Abstract][Full Text] [Related]
6. Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs.
Ogren SO; Fuxe K; Agnati LF; Gustafsson JA; Jonsson G; Holm AC
J Neural Transm; 1979; 46(2):85-103. PubMed ID: 574536
[TBL] [Abstract][Full Text] [Related]
7. Additional evidence that L-5-hydroxytryptophan discrimination models a unique serotonin receptor.
Friedman R; Barrett RJ; Sanders-Bush E
Psychopharmacology (Berl); 1983; 80(3):209-13. PubMed ID: 6137018
[TBL] [Abstract][Full Text] [Related]
8. Pre- and postsynaptic serotonergic manipulations in an animal model of depression.
Nagayama H; Hingtgen JN; Aprison MH
Pharmacol Biochem Behav; 1980 Oct; 13(4):575-9. PubMed ID: 6968915
[TBL] [Abstract][Full Text] [Related]
9. Blockade of a 5-hydroxytryptophan-induced animal model of depression with a potent and selective 5-HT2 receptor antagonist (LY53857).
Hingtgen JN; Fuller RW; Mason NR; Aprison MH
Biol Psychiatry; 1985 Jun; 20(6):592-7. PubMed ID: 3873259
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus properties of L-5-hydroxytryptophan: behavioral evidence for multiple serotonin receptors.
Barrett RJ; Blackshear MA; Sanders-Bush E
Psychopharmacology (Berl); 1982; 76(1):29-35. PubMed ID: 6805004
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic mianserin administration on serotonin metabolism and receptors in the 5-hydroxytryptophan depression model.
Akiyoshi J; Tsuchiyama K; Mizobe Y; Nakamura M; Kuranaga H; Nagayama H
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):165-79. PubMed ID: 7509496
[TBL] [Abstract][Full Text] [Related]
12. Effects of subchronic antidepressant drug treatment on central serotonergic mechanisms in the male rat.
Fuxe K; Ogren SO; Agnati LF; Andersson K; Eneroth P
Adv Biochem Psychopharmacol; 1982; 31():91-107. PubMed ID: 7080902
[TBL] [Abstract][Full Text] [Related]
13. The effect of repeated administration of imipramine, citalopram and mianserin on responsiveness of central serotonergic, alpha 2-adrenergic and cholinergic system in mice.
Maj J; Rogóz Z; Skuza G; Sowińska H
Pol J Pharmacol Pharm; 1989; 41(4):313-9. PubMed ID: 2561380
[TBL] [Abstract][Full Text] [Related]
14. Potentiated 5-hydroxytryptophan induced response suppression in rats following chronic reserpine.
Brugge KL; Hingtgen JN; Aprison MH
Pharmacol Biochem Behav; 1987 Feb; 26(2):287-91. PubMed ID: 3495008
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic treatment with 5-hydroxytryptophan on cortical serotonin receptors in the rat.
Pranzatelli MR
Clin Neuropharmacol; 1988 Jun; 11(3):257-62. PubMed ID: 3261199
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
[TBL] [Abstract][Full Text] [Related]
17. Species dependence of adaptations at the pre- and postsynaptic serotonergic receptors following long-term antidepressant drug treatment.
Schoups AA; De Potter WP
Biochem Pharmacol; 1988 Dec; 37(23):4451-60. PubMed ID: 2849445
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat.
Chaput Y; de Montigny C; Blier P
Neuropsychopharmacology; 1991 Dec; 5(4):219-29. PubMed ID: 1839498
[TBL] [Abstract][Full Text] [Related]
19. Effects of triiodothyronine (T3) on the potentiation by antidepressants of L-5-hydroxytryptophan-induced head-twitches in mice.
Martin P; Massol J; Soubrie P; Puech AJ
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(5):735-48. PubMed ID: 2789414
[TBL] [Abstract][Full Text] [Related]
20. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
